.

Make Better Decisions

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Accenture
Cipla
McKinsey
Johnson and Johnson
Farmers Insurance
Chubb
Cerilliant
Medtronic
Dow
QuintilesIMS

Generated: December 16, 2017

DrugPatentWatch Database Preview

Mupirocin - Generic Drug Details

« Back to Dashboard

What are the generic sources for mupirocin and what is the scope of mupirocin patent protection?

Mupirocin
is the generic ingredient in three branded drugs marketed by Glaxosmithkline, Perrigo New York, Fougera Pharms, Glenmark Pharms, Taro, Teva, and Glenmark Pharms Inc, and is included in ten NDAs. There is one patent protecting this compound. Additional information is available in the individual branded drug profile pages.

Mupirocin has five patent family members in five countries.

There are twelve drug master file entries for mupirocin. Twenty-nine suppliers are listed for this compound.

Pharmacology for mupirocin

Medical Subject Heading (MeSH) Categories for mupirocin

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
GlaxosmithklineBACTROBANmupirocin calciumCREAM;TOPICAL050746-001Dec 11, 1997ABRXYesYes► Subscribe► Subscribe► Subscribe
Glenmark Pharms IncMUPIROCINmupirocin calciumCREAM;TOPICAL201587-001Jan 24, 2013ABRXNoNo► Subscribe► Subscribe► Subscribe
TevaMUPIROCINmupirocinOINTMENT;TOPICAL065085-001Nov 7, 2003ABRXNoNo► Subscribe► Subscribe► Subscribe
TaroMUPIROCINmupirocinOINTMENT;TOPICAL065170-001Sep 23, 2005ABRXNoNo► Subscribe► Subscribe► Subscribe
GlaxosmithklineBACTROBANmupirocin calciumOINTMENT;NASAL050703-001Sep 18, 1995RXYesYes► Subscribe► Subscribe► Subscribe
Perrigo New YorkMUPIROCINmupirocinOINTMENT;TOPICAL065123-001Nov 7, 2003ABRXNoYes► Subscribe► Subscribe► Subscribe
Perrigo New YorkCENTANYmupirocinOINTMENT;TOPICAL050788-001Dec 4, 2002BXRXNoNo► Subscribe► SubscribeY► Subscribe
Fougera PharmsMUPIROCINmupirocinOINTMENT;TOPICAL065192-001Nov 30, 2005ABRXNoNo► Subscribe► Subscribe► Subscribe
GlaxosmithklineBACTROBANmupirocinOINTMENT;TOPICAL050591-001Dec 31, 1987DISCNYesNo► Subscribe► Subscribe► Subscribe
Glenmark PharmsMUPIROCINmupirocinOINTMENT;TOPICAL090480-001Jun 8, 2011ABRXNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Ingredient: mupirocin

Country Document Number Estimated Expiration
Israel123143► Subscribe
Canada2259764► Subscribe
European Patent Office0933081► Subscribe
Germany69900561► Subscribe
Spain2165723► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Deloitte
Chubb
QuintilesIMS
Johnson and Johnson
Chinese Patent Office
Healthtrust
McKinsey
McKesson
Fish and Richardson
Novartis

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot